|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Colucid Pharmaceuticals, Inc. (CLCD) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
15,150,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$46.525 - $46.525 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hogan Linda C. |
Head, Bus. Dev. and Strategy |
• – – |
2016-09-06 |
4 |
OE |
$5.09 |
$19,011 |
I/I |
3,735 |
3,735 |
|
- |
|
| Hogan Linda C. |
Head, Bus. Dev. and Strategy |
• – – |
2016-09-06 |
4 |
AS |
$19.50 |
$895,780 |
D/D |
(45,001) |
0 |
|
- |
|
| Hogan Linda C. |
Head, Bus. Dev. and Strategy |
• – – |
2016-09-06 |
4 |
OE |
$6.75 |
$425,075 |
D/D |
45,001 |
45,001 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,756 |
256,916 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-08-31 |
4 |
AS |
$10.86 |
$1,629 |
D/D |
(150) |
47 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-08-19 |
4 |
AS |
$8.41 |
$4,272 |
D/D |
(508) |
197 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-08-10 |
4 |
AS |
$8.30 |
$4,216 |
D/D |
(508) |
705 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-08-05 |
4 |
AS |
$8.31 |
$12,482 |
D/D |
(1,502) |
253,160 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
254,662 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2016-08-03 |
4 |
S |
$8.15 |
$1,051 |
D/D |
(129) |
3,039 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2016-08-03 |
4 |
S |
$8.15 |
$660,916 |
D/D |
(81,094) |
1,943,109 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2016-08-02 |
4 |
S |
$8.71 |
$279 |
D/D |
(32) |
3,168 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2016-08-02 |
4 |
S |
$8.71 |
$171,744 |
D/D |
(19,718) |
2,024,203 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2016-08-01 |
4 |
S |
$8.82 |
$741 |
D/D |
(84) |
3,200 |
|
- |
|
| Vitullo Nicole |
10% Owner |
– – • |
2016-08-01 |
4 |
S |
$8.82 |
$460,545 |
D/D |
(52,216) |
2,043,921 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-07-29 |
4 |
AS |
$9.09 |
$4,615 |
D/D |
(508) |
1,213 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-07-20 |
4 |
AS |
$8.97 |
$4,557 |
D/D |
(508) |
1,721 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-07-11 |
4 |
AS |
$9.10 |
$4,623 |
D/D |
(508) |
2,229 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-07-05 |
4 |
AS |
$9.73 |
$14,614 |
D/D |
(1,502) |
250,907 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-07-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,755 |
252,409 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-06-30 |
4 |
AS |
$7.01 |
$3,618 |
D/D |
(516) |
2,737 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-06-20 |
4 |
AS |
$7.00 |
$3,500 |
D/D |
(500) |
3,253 |
|
- |
|
| Skwierczynski Raymond |
Head,Pharmaceutical Operations |
• – – |
2016-06-10 |
4 |
AS |
$6.60 |
$3,352 |
D/D |
(508) |
3,753 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-06-06 |
4 |
AS |
$7.25 |
$10,884 |
D/D |
(1,502) |
248,654 |
|
- |
|
| Mathers Thomas P. |
Chief Executive Officer |
• • – |
2016-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,756 |
250,156 |
|
- |
|
97 Records found
|
|
Page 3 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
